• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤在肝癌中的非传统促癌作用。

An unconventional cancer-promoting function of methamphetamine in hepatocellular carcinoma.

机构信息

Department of Pharmacy, The Affiliated Hospital of Ningbo University Medical School, Ningbo, P. R. China.

School of Medicine, Ningbo University, Ningbo, P. R. China.

出版信息

Life Sci Alliance. 2023 Jan 20;6(3). doi: 10.26508/lsa.202201660. Print 2023 Mar.

DOI:10.26508/lsa.202201660
PMID:36669783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9873983/
Abstract

For the past decade, the prevalence and mortality of methamphetamine (METH) use have doubled, suggesting that METH use could be the next substance use crisis worldwide. Ingested METH is transformed into other products in the liver, a major metabolic organ. Studies have revealed that METH causes deleterious inflammatory response, oxidative stress, and extensive DNA damage. These pathological damages are driving factors of hepatocellular carcinoma (HCC). Nonetheless, the potential role of METH in HCC and the underlying mechanisms remain unknown. Herein, we found a higher HCC incidence in METH abusers. METH promoted cellular proliferation, migration, and invasion in two human-derived HCC cells. Consistently, METH uptake promoted HCC progression in a xenograft mouse model. Mechanistically, METH exposure induced ROS production, which activated the Ras/MEK/ERK signaling pathway. Clearance of ROS by NAC suppressed METH-induced activation of Ras/ERK1/2 pathways, leading to arrest of HCC xenograft formation in nude mice. To the best of our knowledge, this is the first study to substantiate that METH promotes HCC progression and inhibition of ROS may reverse this process.

摘要

在过去的十年中,冰毒(METH)的使用率和死亡率翻了一番,这表明 METH 使用可能成为全球下一个药物使用危机。摄入的 METH 在肝脏(主要代谢器官)中转化为其他物质。研究表明,METH 会引起有害的炎症反应、氧化应激和广泛的 DNA 损伤。这些病理损伤是肝细胞癌(HCC)的驱动因素。尽管如此,METH 在 HCC 中的潜在作用及其潜在机制仍不清楚。在此,我们发现 METH 滥用者的 HCC 发病率更高。METH 促进了两种人源性 HCC 细胞的细胞增殖、迁移和侵袭。一致地,METH 摄取促进了异种移植小鼠模型中的 HCC 进展。在机制上,METH 暴露会诱导 ROS 产生,从而激活 Ras/MEK/ERK 信号通路。通过 NAC 清除 ROS 可以抑制 METH 诱导的 Ras/ERK1/2 通路的激活,从而导致裸鼠中 HCC 异种移植物的形成受阻。据我们所知,这是第一项证实 METH 促进 HCC 进展的研究,而抑制 ROS 可能会逆转这一过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/002a2d77cfd5/LSA-2022-01660_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/aa55ef99e93e/LSA-2022-01660_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/0390e921fad7/LSA-2022-01660_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/e6311989562a/LSA-2022-01660_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/39d16eca4096/LSA-2022-01660_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/b689f07bf6df/LSA-2022-01660_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/758a70a25ab7/LSA-2022-01660_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/1453047e6f17/LSA-2022-01660_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/f06533444769/LSA-2022-01660_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/342ee1af88dd/LSA-2022-01660_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/ddd65470090f/LSA-2022-01660_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/0d14e20cfbf2/LSA-2022-01660_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/002a2d77cfd5/LSA-2022-01660_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/aa55ef99e93e/LSA-2022-01660_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/0390e921fad7/LSA-2022-01660_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/e6311989562a/LSA-2022-01660_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/39d16eca4096/LSA-2022-01660_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/b689f07bf6df/LSA-2022-01660_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/758a70a25ab7/LSA-2022-01660_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/1453047e6f17/LSA-2022-01660_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/f06533444769/LSA-2022-01660_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/342ee1af88dd/LSA-2022-01660_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/ddd65470090f/LSA-2022-01660_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/0d14e20cfbf2/LSA-2022-01660_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8b/9873983/002a2d77cfd5/LSA-2022-01660_Fig8.jpg

相似文献

1
An unconventional cancer-promoting function of methamphetamine in hepatocellular carcinoma.甲氨蝶呤在肝癌中的非传统促癌作用。
Life Sci Alliance. 2023 Jan 20;6(3). doi: 10.26508/lsa.202201660. Print 2023 Mar.
2
WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.WNK1 与 KEAP1 相互作用促进 NRF2 稳定,增强肝癌的氧化应激反应。
Cancer Res. 2024 Sep 4;84(17):2776-2791. doi: 10.1158/0008-5472.CAN-23-1167.
3
Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.MLK4 的减少通过降低 ROS/MAPKs 信号转导调控的转移和诱导细胞凋亡来预防肝细胞癌 (HCC)。
Biomed Pharmacother. 2019 Aug;116:108749. doi: 10.1016/j.biopha.2019.108749. Epub 2019 May 6.
4
FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.FOXC1 通过上调 DNMT3B 诱导 CTH 启动子的 DNA 超甲基化促进 HCC 增殖和转移。
J Exp Clin Cancer Res. 2021 Feb 1;40(1):50. doi: 10.1186/s13046-021-01829-6.
5
MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.MCUR1 通过线粒体钙依赖性 ROS/Nrf2/Notch 通路促进肝癌中的上皮-间充质转化和转移。
J Exp Clin Cancer Res. 2019 Mar 25;38(1):136. doi: 10.1186/s13046-019-1135-x.
6
NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.NAD(P)HX 差向异构酶下调通过 ROS/HIF-1α 信号通路促进肝癌的肿瘤进展。
Cancer Sci. 2021 Jul;112(7):2753-2769. doi: 10.1111/cas.14925. Epub 2021 May 4.
7
Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.致癌 Akt-FOXO3 循环有利于促进肿瘤的模式,并增强与氧化损伤相关的肝细胞癌发生。
BMC Cancer. 2019 Sep 5;19(1):887. doi: 10.1186/s12885-019-6110-6.
8
Triggered ROS-Induced DNA Damage to Arrest Cell Cycle Progression and Induce Apoptosis on Human Hepatocellular Carcinoma In Vitro and In Vivo.ROS 诱导的 DNA 损伤可阻止人肝癌细胞周期进程并诱导其凋亡:体内外研究。
Molecules. 2020 Nov 30;25(23):5639. doi: 10.3390/molecules25235639.
9
Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.端粒长度和活性氧水平与肝细胞癌的高死亡率和高复发率呈正相关。
Hepatology. 2018 Apr;67(4):1378-1391. doi: 10.1002/hep.29604. Epub 2018 Feb 22.
10
HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.HSCs 衍生的 COMP 通过激活 MEK/ERK 和 PI3K/AKT 信号通路促进肝细胞癌进展。
J Exp Clin Cancer Res. 2018 Sep 19;37(1):231. doi: 10.1186/s13046-018-0908-y.

引用本文的文献

1
Single-cell RNA-seq Reveals the Inhibitory Effect of Methamphetamine on Liver Immunity with the Involvement of Dopamine Receptor D1.单细胞RNA测序揭示了甲基苯丙胺通过多巴胺受体D1对肝脏免疫的抑制作用。
Genomics Proteomics Bioinformatics. 2024 Oct 15;22(4). doi: 10.1093/gpbjnl/qzae060.
2
Construction of a Novel Cuproptosis-Related ceRNA Network-SNHG3/miR-1306-5p/PDHA1 and Identification of SNHG3 as a Prognostic Biomarker in Hepatocellular Carcinoma.新型铜死亡相关ceRNA网络-SNHG3/miR-1306-5p/PDHA1的构建及SNHG3作为肝细胞癌预后生物标志物的鉴定
ACS Omega. 2023 Oct 3;8(41):38690-38703. doi: 10.1021/acsomega.3c06018. eCollection 2023 Oct 17.
3

本文引用的文献

1
Low concentrations of 4-ABP promote liver carcinogenesis in human liver cells and a zebrafish model.低浓度的 4-ABP 可促进人肝细胞和斑马鱼模型的肝癌发生。
J Hazard Mater. 2022 Feb 5;423(Pt A):126954. doi: 10.1016/j.jhazmat.2021.126954. Epub 2021 Aug 18.
2
Inhibition of PLCβ1 signaling pathway regulates methamphetamine self-administration and neurotoxicity in rats.抑制 PLCβ1 信号通路调节大鼠甲基苯丙胺的自我给药和神经毒性。
Food Chem Toxicol. 2021 Mar;149:111970. doi: 10.1016/j.fct.2021.111970. Epub 2021 Jan 7.
3
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer.
Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells.
癌症代谢:活性氧在癌细胞DNA损伤及凋亡诱导中的作用
Metabolites. 2023 Jun 27;13(7):796. doi: 10.3390/metabo13070796.
ERK磷酸化作为RAS活性的标志物及其在非小细胞肺癌中的预后价值。
Lung Cancer. 2020 Nov;149:10-16. doi: 10.1016/j.lungcan.2020.09.005. Epub 2020 Sep 10.
4
The Complex Interplay between Antioxidants and ROS in Cancer.抗氧化剂与活性氧簇在癌症中的复杂相互作用。
Trends Cell Biol. 2020 Jun;30(6):440-451. doi: 10.1016/j.tcb.2020.03.002. Epub 2020 Apr 14.
5
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review.神经生物学、临床表现和治疗甲基苯丙胺使用障碍:综述。
JAMA Psychiatry. 2020 Sep 1;77(9):959-966. doi: 10.1001/jamapsychiatry.2020.0246.
6
Oncogenic Kras causes myeloproliferation via NLRP3 inflammasome activation.致癌性 Kras 通过 NLRP3 炎性小体激活导致骨髓增生。
Nat Commun. 2020 Apr 3;11(1):1659. doi: 10.1038/s41467-020-15497-1.
7
Patterns and Characteristics of Methamphetamine Use Among Adults - United States, 2015-2018.成年人吸食甲基苯丙胺的模式和特征 - 美国,2015-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):317-323. doi: 10.15585/mmwr.mm6912a1.
8
Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.白皮杉醇诱导结直肠癌细胞中 ROS 介导的细胞凋亡,并抑制 PI3K/AKT/mTOR 和 Ras/MEK/Erk 信号通路。
Biochem Pharmacol. 2020 Jan;171:113680. doi: 10.1016/j.bcp.2019.113680. Epub 2019 Oct 25.
9
Chronic toxicity of methamphetamine: Oxidative remodeling of pulmonary arteries.**标题**: 冰毒的慢性毒性:肺动脉的氧化重塑。
Toxicol In Vitro. 2020 Feb;62:104668. doi: 10.1016/j.tiv.2019.104668. Epub 2019 Oct 16.
10
Breast Cancer Recurrence in the Nipple-Areola Complex After Nipple-Sparing Mastectomy With Immediate Breast Reconstruction for Invasive Breast Cancer.保乳术后即刻乳房重建治疗浸润性乳腺癌后乳头乳晕复合体复发
JAMA Surg. 2019 Nov 1;154(11):1030-1037. doi: 10.1001/jamasurg.2019.2959.